BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Kerui Xu, Shinobu Watanabe-Galloway, Fedja A. Rochling, Jianjun Zhang, Paraskevi A. Farazi, Hongyan Peng, Hongmei Wang, Jiangtao Luo. Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese PatientsAnnals of Global Health 2017; 83(2): 281 doi: 10.1016/j.aogh.2017.02.002
2
Suzanne Sheppard‐Law, Iryna Zablotska‐Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry, Lisa Maher. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus‐related carcinoma and prescribed anti‐viral therapyJournal of Clinical Nursing 2018; 27(13-14): 2673 doi: 10.1111/jocn.14367
3
Jennifer C. Elliott, Deborah S. Hasin, Don C. Des Jarlais. Perceived risk for severe outcomes and drinking status among drug users with HIV and Hepatitis C Virus (HCV)Addictive Behaviors 2016; 63: 57 doi: 10.1016/j.addbeh.2016.06.023
4
Yi-Chun Chen, Yu-Chieh Su, Chung-Yi Li, Chia-Pin Wu, Moon-Sing Lee. A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in TaiwanKidney International 2015; 87(5): 1030 doi: 10.1038/ki.2014.363
5
Ruben Hernaez, Hashem B. El-Serag. Hepatocellular carcinoma surveillance: The road aheadHepatology 2017; 65(3): 771 doi: 10.1002/hep.28983
6
Changqing Zhao, Mingjuan Jin, Richard Hieu Le, Michael Huan Le, Vincent Lingzhi Chen, Michelle Jin, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Young-Suk Lim, Wan-Long Chuang, Ming-Lung Yu, Mindie H. Nguyen. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issueLiver International 2018; 38(3): 503 doi: 10.1111/liv.13555
7
Shu-Mei Tsai, Jung-Ta Kao, Yun-Fang Tsai. Illness trajectory of initial infection for patients with hepatitis C: A qualitative studyNursing & Health Sciences 2019; 21(1): 112 doi: 10.1111/nhs.12568